Diagnosis of metastatic neoplasms: A clinicopathologic and morphologic approach

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 2, 2010, Pages 194-206

  Marchevsky, Alberto M ^a   Gupta, Ruta ^a   Balzer, Bonnie ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NEOPLASM; NEUROENDOCRINE TUMOR; PATHOLOGY; REVIEW; SARCOMA;

ADENOCARCINOMA; ADOLESCENT; ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; NEUROENDOCRINE TUMORS; SARCOMA;

EID: 76449115218     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Greco FA, Hainsworth JD. Introduction: unknown primary cancer. Semin Oncol. 2009;36(1):6-7.
2. Seve P, Mackey J, Sawyer M, et al. Impact of clinical practice guidelines on the diagnostic strategy for carcinomas of unknown primary site: a controlled 'before-after' study. Clin Oncol (R Coll Radiol). 2008;20(8):658-659.
3. Hammar SP. Metastatic adenocarcinoma of unknown primary origin. Hum Pathol. 1998;9(12):1393-1402.
4. Park SY, Kim BH, Kim JH, Lee S, Kang GH. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med. 2007;131(10):1561-1567.
5. Tamboli P, Mohsin SK, Hailemariam S, Amin MB. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med. 2002;126(9):1057-1063.
6. Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26(3):281-291.
7. Campos S, Davey P, Hird A, et al. Brain metastasis from an unknown primary, or primary brain tumour: a diagnostic dilemma. Curr Oncol 2009;16(1): 62-66.
8. Gebauer GP, Farjoodi P, Sciubba DM, et al. Magnetic resonance imaging of spine tumors: classification, differential diagnosis, and spectrum of disease. J Bone Joint Surg Am. 2008;90(suppl 4):146-162.
9. Herbst J, Jenders R, McKenna R, Marchevsky A. Evidence-based criteria to help distinguish metastatic breast cancer from primary lung adenocarcinoma on thoracic frozen section. Am J Clin Pathol. 2009;131(1):122-128.
10. O'Connell FP, Wang HH, Odze RD. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med. 2005;129(3):338-347.
11. Tot T. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract. APMIS. 2000;108(6):467-472.
12. Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer. 2002;38(6):758-763.
13. Young RH. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I - historical perspective, general principles, mucinous tumors including the Krukenberg tumor. Adv Anat Pathol. 2006;13(5): 205-227.
14. Young RH. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: Part II. Adv Anat Pathol. 2007;14(3):149-177.
15. Shaw PH, Adams R, Jordan C, Crosby TD. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network. Clin Oncol (R Coll Radiol). 2007;19(1):87-95.
16. Blaszyk H, Hartmann A, Bjornsson J. Cancer of unknown primary: clinicopathologic correlations. APMIS. 2003;111(12):1089-1094.
17. Bahrami A, Gown AM, Baird GS, Hicks MJ, Folpe AL. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol. 2008;21(7):795-806.
18. Ramalingam P, Adeagbo B, Bollag R, Lee J, Reid-Nicholson M. Metastatic hepatocellular carcinoma with CD138 positivity: an unusual mimic of multiple myeloma? Diagn Cytopathol. 2008;36(10):742-748.
19. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol. 2003;27(8):1031-1051.
20. Marchevsky AM, Wick MR. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol. 2007;15(2):140-144.
21. Marchevsky AM. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med. 2008;132(3):397-401.
22. Joffe N, Antonioli DA. Osteoblastic bone metastases secondary to adenocarcinoma of the pancreas. Clin Radiol. 1978;29(1):41-46.
23. Al-Brahim N, Ross C, Carter B, Chorneyko K. The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center. Ann Diagn Pathol. 2005;9(2):77-80.
24. Chhieng DC, Cangiarella JF, Zakowski MF, et al. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer. 2001;93(5):330-336.
25. Sheridan T, Herawi M, Epstein JI, Illei PB. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Am J Surg Pathol. 2007; 31(9):1351-1355.
26. Maithel SK, Maloney S, Winston C, et al. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2008;15(12):3512-3520.
27. Shafazand S, Gould MK. A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006;1(9):953-959.
28. Gould MK. A clinical prediction model was sensitive but not specific for predicting mortality in pulmonary embolism. ACP J Club. 2006;145(2):53.
29. Vollmer RT, Seigler HF. A model for pretest probability of lymph node metastasis from cutaneous melanoma. Am J Clin Pathol. 2000;114(6):875-879.
30. Bland JM, Altman DG. Bayesians and frequentists. BMJ. 1998;317(7166): 1151-1160.
31. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000; 320(7247):1468.
32. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004; 329(7458):168-169.
33. Marchevsky AM, Wick MR. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol. 2004;35(10):1179-1188.
34. Gupta R, Dastane A, McKenna RJ Jr, Marchevsky AM. What can we learn from the errors in the frozen section diagnosis of pulmonary carcinoid tumors: an evidence-based approach. Hum Pathol. 2009;40(1):1-9.
35. Gupta R, McKenna R Jr, Marchevsky AM. Lessons learned from mistakes and deferrals in the frozen section diagnosis of bronchioloalveolar carcinoma and well-differentiated pulmonary adenocarcinoma: an evidence-based pathology approach [quiz 146]. Am J Clin Pathol. 2008;130(1):11-20.
36. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Data. In: Services UDoHaH, ed. Bethesda, MD: National Cancer Institute; 2005.
37. Murphy W, Grignon D, Perlman E. Kidney tumors in adults. In: Tumors of the Kidney, Bladder and Related Urinary Structures. Washington, DC: American Registry of Pathology; 2004:109-121. AFIP Atlas of Tumor Pathology; 4th series, fascicle 1.
38. Dei Tos AP, Pedeutour F. Atypical lipomatous tumor/well differentiated liposarcoma. In: Fletcher CD, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2004:35-37. World Health Organization Classification of Tumours.
39. Enzinger F, Weiss SW. Liposarcomas. In: Weiss SW, Goldblum JR, eds. Soft Tissue Tumors. 5th ed. St Louis, MO: The CV Mosby Co; 2007:477-519.
40. Kumar V, Abbas A, Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia, PA: Elsevier; 2004.
41. Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS. 2007;115(10):1161-1176.
42. Hofmann WJ, Wockel W, Thetter O, Otto HF. Melanotic paraganglioma of the posterior mediastinum. Virchows Arch. 1995;425(6):641-646.
43. Morgan JM, Lurain JR. Gestational trophoblastic neoplasia: an update. Curr Oncol Rep. 2008;10(6):497-504.
44. Lin JF, Slomovitz BM. Uterine sarcoma 2008. Curr Oncol Rep. 2008;10(6): 512-518.
45. Pantanowitz L, Dezube BJ. Kaposi sarcoma in unusual locations. BMC Cancer. 2008;8:190.
46. Loya AC, Prayaga AK, Arora A, et al. Lymph node metastasis of soft tissue tumors: a cytomorphologic study. Acta Cytol. 2007;51(2):153-160.
47. Kohler HF, Neves RI, Brechtbuhl ER, et al. Cutaneous angiosarcoma of the head and neck: report of 23 cases from a single institution. Otolaryngol Head Neck Surg. 2008;139(4):519-524.
48. Barnhill RL, Benson PJ, Lugassy C. Conspicuous angiotropism of malignant melanoma involving the brain: implications for extravascular migratory metastasis. Am J Dermatopathol. 2009;31(2):205-208.
49. Langille G, Taylor SM, Bullock MJ. Metastatic renal cell carcinoma to the head and neck: summary of 21 cases. J Otolaryngol Head Neck Surg. 2008;37(4): 515-521.
50. Muresan MM, Olivier P, Leclere J, et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer. 2008;15(1):37-49.
51. Rosai J. Rosai and Ackerman's Surgical Pathology. Vol 1 and 2. New York, NY: Mosby; 2004.
52. Ettinger DS, Agulnik M, Cristea M, et al. Occult primary. J Natl Compr Canc Netw. 2008;6(10):1026-1060.
53. Galer CE, Kies MS. Evaluation and management of the unknown primary carcinoma of the head and neck. J Natl Compr Canc Netw. 2008;6(10):1068-1075.
54. Ide F, Mishima K, Tanaka A, Saito I, Kusama K. Mucinous adenocarcinoma of minor salivary glands: a high-grade malignancy prone to lymph node metastasis. Virchows Arch. 2009;454(1):55-60.
55. Silva EG, Young RH. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol. 2007;31(8):1203-1208.
56. Soslow RA. Histologic subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol. 2008;27(2):161-174.
57. Oliva E, Amin MB, Jimenez R, Young RH. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26(2):190-197.
58. Spigel DR, Hainsworth JD, Greco FA. Neuroendocrine carcinoma of unknown primary site. Semin Oncol. 2009;36(1):52-59.
59. Tang LH, Shia J, Soslow RA, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol. 2008;32(10):1429-1443.
60. Weng CT, Chu PY, Liu MT, Chen MK. Small cell carcinoma of the head and neck: a single institution's experience and review of the literature. J Otolaryngol Head Neck Surg. 2008;37(6):788-793.
61. Ozguroglu M, Bilici A, Ilvan S, et al. Determining predominating histologic component in malignant mixed mullerian tumors: is it worth it? Int J Gynecol Cancer. 2008;18(4):809-812.
62. Hennessy BT, Giordano S, Broglio K, et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol. 2006;17(4):605-613.
63. Osako T, Horii R, Ogiya A, et al. Histogenesis of metaplastic breast carcinoma and axillary nodal metastases. Pathol Int. 2009;59(2):116-120.
64. Gallardo A, Prat J. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol. 2009;33(2):278-288.
65. Ferrari A, Casanova M, Massimino M, et al. Synovial sarcoma: report of a series of 25 consecutive children from a single institution. Med Pediatr Oncol. 1999;32(1):32-37.
66. Diemel KD, Klippe HJ, Branseheid D. Pulmonary metastasetomy for osteosarcoma: is it justified? Recent Results Cancer Res. 2009;179:183-208.
67. Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez S, Brigman BE. The clinical management of chondrosarcoma. Curr Treat Options Oncol. 2009;10(1-2):94-106.
68. Yoney A, Eren B, Eskici S, Salman A, Unsal M. Retrospective analysis of 105 cases with uterine sarcoma. Bull Cancer. 2008;95(3):E10-17.
69. Taskinen S, Fagerholm R, Aronniemi J, Rintala R, Taskinen M. Testicular tumors in children and adolescents. J Pediatr Urol. 2008;4(2):134-137.
70. Berney DM. Staging and classification of testicular tumours: pitfalls from macroscopy to diagnosis. J Clin Pathol. 2008;61(1):20-24.
71. Berney DM, Warren AY, Verma M, et al. Malignant germ cell tumours in the elderly: a histopathological review of 50 cases in men aged 60 years or over. Mod Pathol. 2008;21(1):54-59.
72. Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med. 2006;355(1):51-65.
73. Geller AC, Miller DR, Swetter SM, Demierre MF, Gilchrest BA. A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol. 2006;142(4):504-507.